CLINICAL_TRIALS
trial_result
· 2021-04-12
Clinical Trial Update: Evaluation of the Safety, Tolerability and Pharmacokinetics (PK) of GSK3732394 First-Time-in-Human (FTIH) Study [Phase 1]
Summary
Phase 1 first-in-human study evaluating safety, tolerability, and pharmacokinetics of GSK3732394; the trial was terminated and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: TERMINATED | Results posted: 2021-04-12